Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease

J Am Geriatr Soc. 2008 Oct;56(10):1898-903. doi: 10.1111/j.1532-5415.2008.01930.x. Epub 2008 Sep 2.

Abstract

Objectives: To prospectively relate C-reactive protein (CRP), a systemic marker of inflammation, to cognitive change over a 1-year follow-up period.

Design: Prospective 1-year follow-up.

Setting: Outpatient university medical setting.

Participants: Seventy-eight adults (aged 56-84; 39% female) with cardiovascular disease.

Measurements: CRP levels were measured using a high-sensitivity assay, and participants completed a neuropsychological battery at study entry. Neuropsychological assessment was repeated 1 year later.

Results: The association between CRP and change in cognition over the 1-year follow-up was examined using hierarchical linear regression modeling for five cognitive domains (global cognition, language, memory, visuospatial abilities, and attention-executive-psychomotor). High CRP levels were associated with subtle declines in attention-executive-psychomotor performance (CRP beta=-0.22, P=.04) after adjusting for the effects of age and cognitive performance at study entry. CRP was not significantly associated with change in language, memory, or visuospatial performance.

Conclusion: These data provide preliminary evidence that inflammation, potentially contributing to atherosclerotic processes, may underlie the association between high CRP and changes in attention-executive-psychomotor performance.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • C-Reactive Protein / analysis*
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / psychology
  • Cognition Disorders / blood
  • Cognition Disorders / diagnosis
  • Cognition*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests

Substances

  • C-Reactive Protein